FundraiseBase by

Congruence Therapeutics

Raised $39.5M in a Venture round, announced 19 March 2026.

Total raised: $39.5M

Latest round VentureCountry CanadaSector Health

Round

$39.5MVenture, 19 March 2026

Funds Phase I/Ib trial of lead candidate CGX-926 and IND-enabling work on two programs

Amount: $39.5M
Stage: Venture
Announced: 19 March 2026
Lead: Dimension
Other investors: OrbiMed, Amplitude Ventures, Lumira Ventures, Investissement Québec, Driehaus
Use of funds: Funds Phase I/Ib trial of lead candidate CGX-926 and IND-enabling work on two programs
Checked: Announced by the company
Source: Congruence raises $39.5M to take small molecule correctors into the clinic finsmes.com

Company

Computational drug discovery of small molecule correctors for protein misfolding diseases

Based in: Montreal, Canada
Sector: Health
Website: congruencetx.com ↗

Links

Website: congruencetx.com ↗

Questions

How much has Congruence Therapeutics raised?

Congruence Therapeutics raised $39.5M in a Venture round, announced on 19 March 2026.

Who invested in Congruence Therapeutics?

Dimension led. Investors include Dimension, OrbiMed, Amplitude Ventures, Lumira Ventures, Investissement Québec and Driehaus.